The difference in pharmacokinetics of mitomycin C, given either as a single agent or as a part of combination chemotherapy

J. Verweij, M. Stuurman, J. de Vries, H. M. Pinedo

Research output: Contribution to journalArticle

Abstract

In a previous report it was suggested that the total body clearance of mitomycin C (MMC) was different after single agent treatment compared to combination chemotherapy. This suggestion was based on recalculations to one dose level. In the present study a fixed dose of 10 mg/m2 was used. Seven patients on single agent MMC and eight on combination chemotherapy were studied. Terminal half-life varied from 25 to 78 mm, volume of distribution from 7 to 73 l/m2, total body clearance from 11 to 56 l/h per m2, and area under the plasma concentration-time curve (AUC) from 177 to 933 μg/h per 1. Total body clearance was significantly higher and AUC significantly lower in patients on combination chemotherapy. The cause of this difference was not investigated.

Original languageEnglish (US)
Pages (from-to)283-284
Number of pages2
JournalJournal of Cancer Research and Clinical Oncology
Volume112
Issue number3
DOIs
StatePublished - Nov 1986
Externally publishedYes

Fingerprint

Mitomycin
Combination Drug Therapy
Pharmacokinetics
Area Under Curve
Half-Life
Therapeutics

Keywords

  • Combination chemotherapy
  • Mitomycin C
  • Pharmacokinetics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

The difference in pharmacokinetics of mitomycin C, given either as a single agent or as a part of combination chemotherapy. / Verweij, J.; Stuurman, M.; de Vries, J.; Pinedo, H. M.

In: Journal of Cancer Research and Clinical Oncology, Vol. 112, No. 3, 11.1986, p. 283-284.

Research output: Contribution to journalArticle

@article{7a3c6121dbc646d0ae22199f05e331a4,
title = "The difference in pharmacokinetics of mitomycin C, given either as a single agent or as a part of combination chemotherapy",
abstract = "In a previous report it was suggested that the total body clearance of mitomycin C (MMC) was different after single agent treatment compared to combination chemotherapy. This suggestion was based on recalculations to one dose level. In the present study a fixed dose of 10 mg/m2 was used. Seven patients on single agent MMC and eight on combination chemotherapy were studied. Terminal half-life varied from 25 to 78 mm, volume of distribution from 7 to 73 l/m2, total body clearance from 11 to 56 l/h per m2, and area under the plasma concentration-time curve (AUC) from 177 to 933 μg/h per 1. Total body clearance was significantly higher and AUC significantly lower in patients on combination chemotherapy. The cause of this difference was not investigated.",
keywords = "Combination chemotherapy, Mitomycin C, Pharmacokinetics",
author = "J. Verweij and M. Stuurman and {de Vries}, J. and Pinedo, {H. M.}",
year = "1986",
month = "11",
doi = "10.1007/BF00395925",
language = "English (US)",
volume = "112",
pages = "283--284",
journal = "Journal of Cancer Research and Clinical Oncology",
issn = "0171-5216",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - The difference in pharmacokinetics of mitomycin C, given either as a single agent or as a part of combination chemotherapy

AU - Verweij, J.

AU - Stuurman, M.

AU - de Vries, J.

AU - Pinedo, H. M.

PY - 1986/11

Y1 - 1986/11

N2 - In a previous report it was suggested that the total body clearance of mitomycin C (MMC) was different after single agent treatment compared to combination chemotherapy. This suggestion was based on recalculations to one dose level. In the present study a fixed dose of 10 mg/m2 was used. Seven patients on single agent MMC and eight on combination chemotherapy were studied. Terminal half-life varied from 25 to 78 mm, volume of distribution from 7 to 73 l/m2, total body clearance from 11 to 56 l/h per m2, and area under the plasma concentration-time curve (AUC) from 177 to 933 μg/h per 1. Total body clearance was significantly higher and AUC significantly lower in patients on combination chemotherapy. The cause of this difference was not investigated.

AB - In a previous report it was suggested that the total body clearance of mitomycin C (MMC) was different after single agent treatment compared to combination chemotherapy. This suggestion was based on recalculations to one dose level. In the present study a fixed dose of 10 mg/m2 was used. Seven patients on single agent MMC and eight on combination chemotherapy were studied. Terminal half-life varied from 25 to 78 mm, volume of distribution from 7 to 73 l/m2, total body clearance from 11 to 56 l/h per m2, and area under the plasma concentration-time curve (AUC) from 177 to 933 μg/h per 1. Total body clearance was significantly higher and AUC significantly lower in patients on combination chemotherapy. The cause of this difference was not investigated.

KW - Combination chemotherapy

KW - Mitomycin C

KW - Pharmacokinetics

UR - http://www.scopus.com/inward/record.url?scp=0022917402&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022917402&partnerID=8YFLogxK

U2 - 10.1007/BF00395925

DO - 10.1007/BF00395925

M3 - Article

C2 - 3097025

AN - SCOPUS:0022917402

VL - 112

SP - 283

EP - 284

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

SN - 0171-5216

IS - 3

ER -